Clinical trial
Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole
NCT00268554 · Radboud University Medical Center, Other · Completed
Key facts
| NCT number | NCT00268554 |
|---|---|
| Title | Enhancement of Postocclusive Reactive Hyperaemia by Dipyridamole |
| Official title | Enhancement of Postocclusive Reactive Hyperaemia |
| Lead sponsor | Radboud University Medical Center, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Hyperemia, Hypoxia |
| Intervention type | Drug |
| Interventions | dipyridamole, caffeine |
| Enrollment | 12 |
| Start date | Dec 1, 2005 |
| Completion | Jul 1, 2006 |
| First posted | Dec 22, 2005 |
| Last update posted | Mar 28, 2008 |
| Countries | Netherlands |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: